In the struggle between virus and host, control over the cell's death machinery is crucial for survival. Viruses are obligatory intracellular parasites and, as such, must modulate apoptotic pathways to control the lifespan of their host in order to complete their replication cycle. Many of the counter-assaults mounted by the immune system incorporate activation of the apoptotic pathway-particularly by members of the tumor necrosis factor cytokine family-as a mechanism to restrict viral replication. Thus, apoptosis serves as a powerful selective pressure for the virus to evade. However, for the host, success is harsh and potentially costly, as apoptosis often contributes to pathogenesis. Here we examine some of the molecular mechanisms by which viruses manipulate the apoptotic machinery to their advantage and how we (as vertebrates) have evolved and learned to cope with viral evasion.
cytokines ͉ immune evasion ͉ T lymphocytes ͉ costimulation E fficient activation and differentiation of T cells depends on recognition of antigen and cooperating signals (cosignaling) that provoke either positive or inhibitory effects. Inhibitory pathways help maintain immune tolerance to self tissues. In the absence of inhibitory signals or with sustained positive cosignaling, tolerance can be overridden, leading to autoimmune responses. Two major groups of cosignaling receptors are recognized, those with an Ig-like fold, such as CTLA-4 (1), CD28 (2), PD1 (3), and B and T lymphocyte attenuator (BTLA) (4, 5), and those belonging to the TNF receptor (TNFR) superfamily, including OX40, 41BB, CD27, CD30, and herpesvirus entry mediator (HVEM; TNFR superfamily 14) among others (6-9). Generally, positive cosignaling receptors in the Ig family act by sustaining antigen receptor-associated kinase activity, whereas their inhibitory counterparts contain an immunoreceptor tyrosine-based inhibitory motif that recruits phosphatases [e.g., Src homology 2 (SH2) domain phosphatase-1; SH2 domaincontaining inositol polyphosphate 5-phosphatase] attenuating antigen receptor signaling (1, 2, 10). By contrast, the cosignaling TNFRs activate serine kinases promoting expression of survival and proinflammatory genes through the transcription factors NF-B and activator protein 1, whereas some other TNFRs induce apoptosis, negatively regulating T cells by cellular elimination (6).A unique inhibitory cosignaling pathway for T cells was recently defined (11,12), which involves the engagement of BTLA by HVEM, connecting the Ig and TNFR cosignaling families. HVEM binding activates tyrosine phosphorylation of the immunoreceptor tyrosine-based inhibitory motif in BTLA and induces the association with the protein tyrosine phosphatases Src homology domain 1 and 2 required for inhibitory signaling (13). However, HVEM can also act as a positive cosignaling receptor (reviewed in ref. 8) by binding TNF-related ligands LIGHT (TNF superfamily 14) and lymphotoxin ␣ (LT␣, TNF superfamily 2) (14). A fourth ligand of HVEM is envelope glycoprotein D (gD) of herpes simplex virus (HSV; ␣-herpesvirus) from which its name was derived (15, 16).Thus, HVEM has the potential to serve as a molecular switch mediating either positive or inhibitory signaling, depending on which of its four ligands are bound. Moreover, the directionality of signaling is not clear, as the hierarchy of ligand occupancy and relative affinities of the interactors are not well defined. The N-terminal extracellular region of HVEM is composed of four pseudorepeats of a cysteine-rich domain (CRD), characteristic of the TNFR superfamily; each repeat contains three disulfide bonds that fold into complex loops depending in part on the spacing of the cysteines (17). Mutagenesis studies (18) . Domain-swapping experiments revealed the CRD1 of HVEM was sufficient to mediate BTLA binding (11). These observations raised the issue of the location of the BTLA binding site relative to gD and LIGHT.Here, w...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.